A Study of the Natural Progression of Interstitial Lung Disease (ILD)

RECRUITING

I'm interested ...!!

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Conditions:

Interstitial Lung Diseases Idiopathic Pulmonary Fibrosis Sarcoidosis Connective Tissue Disorder

Study Start (Actual) 2005-09

Primary Completion (Estimated) 2025-12

Study Completion (Estimated) 2025-12

Enrollment (Estimated) 4000

Study Type OBSERVATIONAL

Phase N/A

Locations:

📍 Chicago, Illinois, United States

Eligibility Criteria

Description

Inclusion Criteria:

* Interstitial lung disease

Exclusion Criteria:

* Does not have Interstitial lung disease

Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)

Sexes Eligible for Study: ALL

Accepts Healthy Volunteers: Yes

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted2007-05-03
First Submitted that Met QC Criteria2007-05-04
First Posted2007-05-07

Study Record Updates

Last Update Submitted that Met QC Criteria2023-11-29
Last Update Posted2023-11-30
Last Verified2023-11